Clinical characteristics and management of patients with nonalcoholic steatohepatitis in a real-world setting: analysis of the Ipsos NASH therapy monitor database

Table 1 Attrition of reported patients by sampled physician specialty

Total patient sample (2016 and 2017)	Patient medical records provided by all healthcare providers	Patient medical records provided by Primary Care Physicians	Patient medical records provided by Gastroenterologists	Patient medical records provided by Hepatologists	Patient medical records provided by Endocrinologists
All^	3,143	220	1,491	822	610
NAFLD fibrosis score less than -1.455	377	50	166	65	96
No NASH diagnosis confirmed by biopsy	201	8	101	25	67
Unknown completeness*	629	60	243	71	255
Final sample	2,366	142	1,174	735	315

^Data reflects patients excluded from analysis and may overlap among the three variables
*No fibrosis score at diagnosis AND no current fibrosis score
NASH, nonalcoholic steatohepatitis; NAFLD, nonalcoholic fatty liver disease
Source: Ipsos NASH Therapy Monitor (NASH-treating physicians in US reporting on patients seen in consultation in 2016 [n = 174] and 2017 [n = 164]; data collected online). Data © Ipsos 2022, all rights reserved.

ISSN: 1471-230X